PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1400724
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1400724
Oral Macromolecular Formulation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
The global Oral Macromolecule Formulation Market is experiencing remarkable growth, with revenues reaching US$ 18 million in 2024. Market analysts anticipate a steady Compound Annual Growth Rate (CAGR) of 7%, propelling the market to an estimated valuation of approximately US$ 28 million by the end of 2031.
Oral Delivery: The Preferred Route
Oral drug delivery has emerged as the most desirable route due to its advantages, including the potential for solid formulations with extended shelf life, continuous distribution, and enhanced immune response.
The numerous risks associated with injections, such as needle-related injuries, pain, and needle stick injuries, can be mitigated by oral macromolecule formulations. Approximately 385,000 sharp injuries occur among healthcare workers in the US each year, highlighting the importance of safer alternatives. Pediatric patients, in particular, have a high demand for oral formulations due to the discomfort associated with injections.
Growing Preference for Oral Administration
Oral administration has become the most popular method of drug delivery due to its non-invasiveness, patient compliance, and ease of use. It is especially crucial for elderly and physically fragile individuals, enabling self-administration of medications without the need for assistance.
Affordability and Accessibility
Oral macromolecule formulations are in significant demand, particularly in low-income regions, owing to their cost-effectiveness. Researchers and contract manufacturers specializing in oral macromolecule formulations are dedicated to simplifying patients' lives by offering novel and practical single-unit dosage forms.
Diabetes and Oral Macromolecular Formulations
The global rise in diabetes has driven the demand for oral macromolecular formulations, as diabetic patients may require insulin therapy. The oral formulation of biomolecules like insulin offers potential advantages over intravenous administration, which can be uncomfortable and challenging for patients.
Market Growth Drivers
Introduction of Novel Drug Delivery Systems: Pharmaceutical manufacturers are actively exploring various methods to enhance the oral administration of biologics, aiming to overcome enzymatic and acidic breakdown.
Challenges in Market Growth
Drawbacks and Poor Absorption: The absorption of oral macromolecule formulations faces physiological barriers, and many macromolecules are susceptible to rapid degradation by digestive enzymes. Gastric pH can also impact drug absorption.
Booming U.S. Market
Key Companies Covered:
Indication:
End User:
Region:
Table of Contents
1. Executive Summary
- 1.1. Global Oral Macromolecular Formulation Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2023
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
3. Global Oral Macromolecular Formulation Market Outlook, 2018 - 2031
4. North America Oral Macromolecular Formulation Market Outlook, 2018 - 2031
5. Europe Oral Macromolecular Formulation Market Outlook, 2018 - 2031
6. Asia Pacific Oral Macromolecular Formulation Market Outlook, 2018 - 2031
7. Latin America Oral Macromolecular Formulation Market Outlook, 2018 - 2031
8. Middle East & Africa Oral Macromolecular Formulation Market Outlook, 2018 - 2031
9. Competitive Landscape
10. Appendix
